Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease

Emerging Infectious Diseases
A E FioreJay C Butler

Abstract

To estimate the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates submitted to the Pneumococcal Sentinel Surveillance System from 1984 to 1996 from 48 vaccinated and 125 unvaccinated children 2 to 5 years of age. Effectiveness against invasive disease caused by serotypes included in the vaccine was 63%. Effectiveness against serotypes in the polysaccharide vaccine but not in a proposed seven-valent protein conjugate vaccine was 94%.

References

Jul 5, 1979·The New England Journal of Medicine·V I AhonkhaiG Schiffman
May 1, 1977·American Journal of Epidemiology·K T CopelandR H Holbrook
Nov 21, 1991·The New England Journal of Medicine·E D ShapiroJ D Clemens
Dec 12, 1990·JAMA : the Journal of the American Medical Association·C B GableK Baum
May 1, 1988·Annals of Internal Medicine·R V SimsJ S Schwartz
May 26, 1984·British Medical Journal·A B JohnG R Serjeant
Mar 1, 1981·Reviews of Infectious Diseases·C V Broome
Oct 20, 1993·JAMA : the Journal of the American Medical Association·J C ButlerR R Facklam
Oct 1, 1995·Journal of Clinical Microbiology·J Henrichsen
Feb 16, 1981·Proceedings of the American Philosophical Society·R Austrian

❮ Previous
Next ❯

Citations

Mar 12, 2002·Pediatric Pulmonology·S L Kaplan
Jul 18, 2002·Scandinavian Journal of Immunology·T Wuorimaa, H Käyhty
Aug 30, 2002·Seminars in Pediatric Infectious Diseases·Gary D Overturf
Aug 16, 2000·Current Opinion in Pediatrics·A Y Koh, H H Bernstein
Jan 6, 2005·Drugs·Jolanta Bernatoniene, Adam Finn
Sep 21, 2012·Expert Opinion on Biological Therapy·David Pace
Sep 16, 2011·Vaccine·Angela Gentile, Virginia Bazán
Mar 1, 2016·Expert Opinion on Drug Safety·Susanna Esposito, Nicola Principi
Jul 28, 2015·Human Vaccines & Immunotherapeutics·Annika M HofstetterSusan L Rosenthal
Jul 20, 2001·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·B Shields
Sep 9, 2005·The Laryngoscope·Christiane HeyStefan Zielen
Apr 21, 2012·Current Opinion in Infectious Diseases·Ray BorrowClaire-Anne Siegrist
Nov 4, 2000·The Medical Journal of Australia·V L KrauseA Merianos
Mar 16, 2019·Microbiology Spectrum·Allister J LoughranElaine I Tuomanen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.